#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal artery occlusion Multiple system atrophy Fragile X syndrome White matter lesion Acute graft versus host disease in skin Malignant melanoma Neuropathic arthropathy Amyloidosis Primary amyloidosis Castleman's disease Fallopian tube cancer Rett syndrome Uterine leiomyosarcoma Waldenstrom's macroglobulinaemia recurrent Usher's syndrome More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Diagnostics Progressive multifocal leukoencephalopathy – Treatment Aicardi-Goutieres syndrome – Life with Disease Breast angiosarcoma metastatic – Diagnostics Carcinoid syndrome – Basic Information Fragile X syndrome – Diagnostics Chordoma – Life with Disease Idiopathic inflammatory myopathy – Basic Information Mast cell activation syndrome – Diagnostics Langerhans cell sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    64Cu-Dota-Ae105 Giroctocogene Fitelparvovec Bosentan Dulaglutide Clemastine Fumarate Thiotepa IHMA-2121771-1 Melphalan Flufenamide Rivaroxaban Sodium Tolebrutinib Colestyramine Mezigdomide Brexpiprazole Fumarate Zidovudine Emibetuzumab Depemokimab Obinutuzumab Raludotatug Deruxtecan Tacrolimus More therapies…

    Learn about Your Condition

    Angiosarcoma recurrent Diabetic foot Adenomatous polyposis coli Injection site pain Heparin resistance Indolent systemic mastocytosis Iron overload Hyperphagia Metastatic malignant melanoma Small intestine leiomyosarcoma Cancer fatigue Colon cancer stage III Spondylolisthesis Peripheral artery stenosis Familial mediterranean fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetes mellitus

  • Study of Metformin Treatment to Maintain Type 2 Diabetes Remission in Patients After Bariatric Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Metformin Embonate
    France

  • Study on the Safety and Effects of VX-264 for Patients with Type 1 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Vx-264
    Germany Italy The Netherlands

  • Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathic arthropathy
    • Diabetes mellitus
    Investigated Drugs:
    • Denosumab
    • Saline
    The Netherlands

  • Study on the Effectiveness of Oxygen Therapy for Patients with Diabetic Foot Ulcers

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic skin ulcer
    • Diabetes mellitus
    Investigated Drugs:
    • Oxygen
    The Netherlands Spain

  • Study on the Effects of Alendronate on Bone and Blood Sugar Markers in Patients with Diabetes and Osteopenia/Osteoporosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteopenia
    • Type 1 diabetes mellitus
    • Osteoporosis
    Investigated Drugs:
    • Alendronate Sodium Monohydrate
    Denmark

  • A Study of Long-Term Safety of Teplizumab in Children and Adolescents with Recently Diagnosed Type 1 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diabetes mellitus
    Investigated Drugs:
    • Teplizumab
    Belgium Czechia France Germany Poland
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!